Small molecule inhibitors of N-terminus activation of the androgen receptor

Details for Australian Patent Application No. 2009284668 (hide)

Owner British Columbia Cancer Agency Branch The University of British Columbia

Inventors Sadar, Marianne D.; Mawji, Nasrin R.; Wang, Jun; Andersen, Raymond J.; Williams, David E.; Leblanc, Mike; Yan, Lu-Ping

Agent Davies Collison Cave

Pub. Number AU-A-2009284668

PCT Pub. Number WO2010/020055

Priority 61/136,277 22.08.08 US

Filing date 24 August 2009

Wipo publication date 25 February 2010

International Classifications

C07D 207/38 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/020055 Priority application(s): WO2010/020055

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009284671-A method of diagnosing a respiratory disease

2009284655-Soluble canola protein isolate production from protein micellar mass